The University of Oxford and the University of Navarra have signed an agreement agreement to research and apply new techniques in immunotherapy to cancer patients. This is the only active agreement in...
Read moreLa Fundación ”la Caixa” ha otorgado tres nuevas ayudas a proyectos de innovación biomédica puntera en el marco de la convocatoria CaixaResearch Consolidate. El objetivo final de CaixaResearch C...
Read moreGenital candidiasis is a common type of infection caused by the yeast, Candida. Although it is a common disease in the population, there are differences between women and men that are not so well know...
Read moreProfesionales del Instituto de Investigación Sanitaria INCLIVA y del Hospital Clínico de València han mantenido esta mañana un encuentro con pacientes y asociaciones de pacientes para mostrar la s...
Read moreThe National Institutes of Health (NIH-NIAID) in the USA has established a consortium to identify the environmental factors and underlying immune mechanisms that may explain the variation in response ...
Read moreA study with the participation of more than 769 professionals from the Northern Metropolitan Primary Care of the ICS and the Germans Trias Hospital has confirmed that antibodies against SARS-CoV-2 are...
Read moreThe Ministry of Science and Innovation has awarded two projects from the "Call for strategic projects aimed at ecological transition and digital transition" and three projects from the "Call for publi...
Read morePero el aumento de las resistencias a los antibióticos pone en riesgo la efectividad de los tratamientos. Tal es así que las resistencias antimicrobianas suponen un problema de salud pública a nive...
Read moreLos investigadores han observado que las bacterias recurren al suicidio celular cuando la infección vírica se produce de manera acelerada
Read moreThe herpes zoster virus is the cause of chickenpox, which is how the disease manifests itself the first time the person is infected. When the virus is reactivated it can give rise to cutaneous herpes ...
Read moreResearchers at Pulmobiotics, a start-up founded in 2020 at the Centre for Genomic Regulation (CRG) in Barcelona, have begun work on a ‘living medicine’ to improve the efficacy of lung cancer treat...
Read more